Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

PharmGen Science Inc (004720)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
5,240 +40    +0.77%
26/04 - Closed. Currency in KRW ( Disclaimer )
Type:  Equity
Market:  South Korea
ISIN:  KR7004720009 
  • Volume: 44,027
  • Bid/Ask: 5,240 / 5,250
  • Day's Range: 5,170 - 5,250
PharmGen Science 5,240 +40 +0.77%

004720 Balance Sheet

 
Featured here, the Balance Sheet for PharmGen Science Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 95327.31 92878.78 93104.99 77414.93
Cash and Short Term Investments 37437.38 35379.22 36691.03 16217.3
Cash - - - -
Cash & Equivalents 36905.53 34847.36 36159.75 15686.01
Short Term Investments 531.85 531.85 531.28 531.28
Total Receivables, Net 35616.71 31375.94 28703.81 30487.81
Accounts Receivables - Trade, Net 35616.71 30559.69 28703.81 30487.81
Total Inventory 20713.29 24973.38 25690.08 20134.37
Prepaid Expenses - - - -
Other Current Assets, Total 1559.93 1150.25 2020.08 10575.46
Total Assets 335917.1 343114.51 342724.75 324052.71
Property/Plant/Equipment, Total - Net 41272.57 41844.53 42688.48 42895.98
Property/Plant/Equipment, Total - Gross 59888.02 60883.78 60954.31 60474.94
Accumulated Depreciation, Total -18615.45 -19039.26 -18265.83 -17578.96
Goodwill, Net - - - -
Intangibles, Net 446.37 453.3 464.34 471.23
Long Term Investments 182003.49 191249.42 189615.14 186594.46
Note Receivable - Long Term - 290.49 - -
Other Long Term Assets, Total 10895.9 10807.38 10914.01 11050.2
Other Assets, Total -6840.17 1686.41 5475.42 6379.2
Total Current Liabilities 63172 75626.14 77170.73 68611.74
Accounts Payable 4867.9 6285.47 8172.97 5469.72
Payable/Accrued - - - -
Accrued Expenses 6187.34 5572.54 5494.92 4668.32
Notes Payable/Short Term Debt 37020.28 50333.77 50679.2 39056.98
Current Port. of LT Debt/Capital Leases 410.86 465.58 534.53 649.07
Other Current liabilities, Total 14685.61 12968.79 12289.11 18767.64
Total Liabilities 107705.79 121993.42 122530.44 111780.86
Total Long Term Debt 532.34 569.06 651.63 512.95
Long Term Debt - - - -
Capital Lease Obligations 532.34 569.06 651.63 512.95
Deferred Income Tax 29020.59 31995.05 31419.7 29407.88
Minority Interest -10.11 -9.76 -9.62 -9.47
Other Liabilities, Total -22029.31 -36520.83 -37381.2 -25799.22
Total Equity 228211.31 221121.09 220194.31 212271.86
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 9001.23 7998.9 7923.39 7915.44
Additional Paid-In Capital 81598.69 70810.5 69988.38 69896.92
Retained Earnings (Accumulated Deficit) 130092.9 131137.02 133258.46 126554.33
Treasury Stock - Common -587.16 -587.16 -587.16 -587.16
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 8105.65 11761.84 9611.24 8492.33
Total Liabilities & Shareholders' Equity 335917.1 343114.51 342724.75 324052.71
Total Common Shares Outstanding 17.58 15.96 15.99 15.79
Total Preferred Shares Outstanding - - - -
* In Millions of KRW (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

004720 Comments

Write your thoughts about PharmGen Science Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email